Expert Interviews

Annie Lambert, PharmD, BCSCP, discusses pharmacies’ regulation and compliance needs when it comes to dispensing compounded GLP-1s.

Many states are pushing pharmacies to move beyond the traditional dispensing role into more robust clinical care.

From proposed transparency rules to Medicare price negotiation programs, the stakes are high for pharmacy reimbursement and the sustainability of independent practices.

Mark Cuban Cost Plus Drug Company challenges pharmacy benefit managers' opacity, expands affordable drug access, and supports community pharmacies.

Drug shortages remain one of the most persistent challenges in pharmacy practice, but emerging technologies like AI are beginning to shift the landscape for pharmacies and public health as a whole.

Harps pharmacists reveal how smart workflow powers point‑of‑care testing, prescribing, and billing—scalable clinical services for regional chains.

Lani Bertrand, senior director of clinical marketing & thought leadership at Omnicell, discusses the consistent drivers of drug shortages in the US.

With a key exemption under DSCSA expiring at the end of the year, Matt Sample from Cencora helps pharmacies understand the tools and processes they need now to best comply with the law.

Matt Sample from Cencora discusses current DSCSA developments on the rise for pharmacy businesses in 2026—namely small dispensers that have been under exemption.

With patients and pharmacists existing in new territories since the COVID-19 pandemic, at-home diagnostic testing has come a long way in improving the potential for convenient access to care.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Mohammad Al Numan, BS, MS, a 2025-27 University of Illinois Chicago/Takeda Fellow in Health Economics and Outcomes Research.

Pharmacists lead safer postsurgical pain care, using multimodal nonopioid options and tight opioid stewardship from pre-operation through home.

Community pharmacists strengthen disaster response by coordinating vaccines, bridging care gaps, and securing lifesaving meds under pressure.

With the federal government continuing its reconsideration of vaccine guidelines in the US, Jeff Goad, PharmD, MPH, explains what it means for community pharmacies.

Timothy Aungst, PharmD; Ravi Patel, PharmD, MBA, MS; and Smit Patel, PharmD; provided much-needed nuance to the evolving nature of DTP pharmacy models in today’s landscape.

Anne Cassity, senior vice president of government affairs at NCPA, discusses the next moves of both PBMs and community pharmacy advocates following the signing of HR 7148.

With President Trump’s signing of HR 7148, experts are now racing to get a grasp on the monumental shifts in pharmacy that will stem from this new legislation.

As lawmakers continue to deliberate on HR 7148, pharmacy law expert, Jesse Dresser, Esq, joined Drug Topics to discuss its provisions related to PBMs.

If signed by President Trump in time to avoid a government shutdown, HR 7148 has potential to enforce significant change in the prescription drug supply chain.

As more prescription drugs move to OTC, the pharmacist’s role in their communities are continuing to shift as well.

With unprecedented changes to Medicare Part D plans at the top of the year, experts from ASCP help pharmacy businesses understand key provisions under the IRA.

Representatives from the American Society of Consultant Pharmacists joined Drug Topics to discuss the day 1 reality of the Medicare Drug Price Negotiation Program.

To celebrate National Pharmacist Day, regonized every year on January 12, Meagan Brown, PharmD, BCACP, discussed the current state of nationally recognizing pharmacists as clinical providers.

Meagan Brown, PharmD, BCACP, discusses the nuances of pharmacists’ provider status and its evolution within the greater health care community.

Meagan Brown, PharmD, BCACP, discusses her career journey in various pharmacy roles during National Pharmacist Day, January 12.

From gaps in care to formulary challenges, Susan Thomas, RN, explains how her independent PBM is working with pharmacists to improve women’s health outcomes.

Susan Thomas, RN, joined Drug Topics to discuss current gaps in women’s health and how pharmacists are stepping in to counsel in this space more than ever before.